speb/financial-data huggingface dataset:
EMR.AX cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: -6452000.00
EMR.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -19227000.00
EMR.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -19227000.00
EMR.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -22589000.00
EMR.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -14683000.00
EMR.AX cash_flow (annual, 2023-06-30) — Net Other Investing Changes: -1591000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Net PPE: 288679000.00
EMR.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -8606000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 320123000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Non Current Deferred Assets: 17684000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Assets: 17684000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 351000.00
EMR.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: 134839000.00
EMR.AX income_statement (annual, 2023-06-30) — Normalized Income: 66281000.00
EMR.AX income_statement (annual, 2023-06-30) — Operating Income: 105370000.00
EMR.AX income_statement (annual, 2023-06-30) — Operating Revenue: 297666000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 595461968.00
EMR.AX cash_flow (annual, 2023-06-30) — Other Cash Paymentsfrom Operating Activities: -19662000.00
EMR.AX cash_flow (annual, 2023-06-30) — Other Cash Receiptsfrom Operating Activities: 6342000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Current Assets: 180000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Current Liabilities: 37254000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 6832000.00
EMR.AX income_statement (annual, 2023-06-30) — Other Gand A: 2053000.00
EMR.AX income_statement (annual, 2023-06-30) — Other Income Expense: -11866000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Inventories: 38141000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Investments: 3318000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 55630000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Non Current Liabilities: 43900000.00
EMR.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: -11866000.00
EMR.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 25392000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Payable: 10506000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Properties: 127621000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 15919000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 502000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Payables: 23815000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 23815000.00
EMR.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -169104000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 7000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 1974000.00
EMR.AX income_statement (annual, 2023-06-30) — Pretax Income: 70915000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Properties: 80934000.00
EMR.AX cash_flow (annual, 2023-06-30) — Purchase Of Business: -3792000.00
EMR.AX cash_flow (annual, 2023-06-30) — Purchase Of Investment: -6452000.00
EMR.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -8606000.00
EMR.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Customers: 297572000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Receivables: 15919000.00
EMR.AX income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 115941000.00
EMR.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 42445000.00
EMR.AX income_statement (annual, 2023-06-30) — Rent And Landing Fees: 365000.00
EMR.AX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -19227000.00
EMR.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -37000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: 23084000.00
EMR.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 6100000.00
EMR.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 8518000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Share Issued: 595461968.00
EMR.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 320123000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 320123000.00
EMR.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
EMR.AX income_statement (annual, 2023-06-30) — Tax Provision: 4634000.00
EMR.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.07
EMR.AX cash_flow (annual, 2023-06-30) — Taxes Refund Paid Direct: -21152000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Total Assets: 492990000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 320123000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 323982000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 169008000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 365311000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 70876000.00
EMR.AX income_statement (annual, 2023-06-30) — Total Other Finance Cost: 2920000.00
EMR.AX balance_sheet (annual, 2023-06-30) — Working Capital: 29547000.00
EMR.AX income_statement (annual, 2024-06-30) — +Operating Expense: 88482000.00
EMR.AX income_statement (annual, 2024-06-30) — +Total Revenue: 366038000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 17615000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -59426000.00
EMR.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 620924000.00
EMR.AX income_statement (annual, 2024-06-30) — Basic EPS: 0.14
EMR.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 70963000.00
EMR.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -5885000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 451667000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 144101000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 144603000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Cash Equivalents: 70000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 144031000.00
EMR.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: -74832000.00
EMR.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -10088000.00
EMR.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: 156379000.00
EMR.AX cash_flow (annual, 2024-06-30) — Changes In Cash: 71459000.00
EMR.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -189789000.00
EMR.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 375812000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Common Stock: 451667000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 557968000.00
EMR.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 3945000.00
EMR.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -272000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Construction In Progress: 2585000.00
EMR.AX income_statement (annual, 2024-06-30) — Cost Of Revenue: 125630000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Current Assets: 203062000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 20802000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Current Deferred Taxes Liabilities: 20802000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 119534000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Current Provisions: 27382000.00
EMR.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 36964000.00
EMR.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 36964000.00
EMR.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 36964000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Derivative Product Liabilities: 17248000.00
EMR.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 620924000.00
EMR.AX income_statement (annual, 2024-06-30) — Diluted EPS: 0.13
EMR.AX income_statement (annual, 2024-06-30) — EBIT: 139827000.00
EMR.AX income_statement (annual, 2024-06-30) — EBITDA: 176791000.00
EMR.AX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: 1679000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Employee Benefits: 463000.00
EMR.AX cash_flow (annual, 2024-06-30) — End Cash Position: 144101000.00
EMR.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: -74832000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: 1548000.00
EMR.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: 150494000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 11160000.00
EMR.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 10525000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 490954000.00
EMR.AX income_statement (annual, 2024-06-30) — Gross Profit: 240408000.00
EMR.AX cash_flow (annual, 2024-06-30) — Income Tax Paid Supplemental Data: 34414000.00
EMR.AX income_statement (annual, 2024-06-30) — Interest Expense: 19784000.00
EMR.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 19784000.00
EMR.AX income_statement (annual, 2024-06-30) — Interest Income: 5035000.00
EMR.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 5035000.00
EMR.AX cash_flow (annual, 2024-06-30) — Interest Paid Cff: -31017000.00
EMR.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 4770000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Inventory: 45961000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 557968000.00
EMR.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -10088000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Investments And Advances: 3321000.00
EMR.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 3945000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Land And Improvements: 28598000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Leases: 546000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Loans Receivable: 51000.00
EMR.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -32220000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Long Term Provisions: 15338000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 73781000.00
EMR.AX cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: -174000.00
EMR.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 3673000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Income: 80697000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 80697000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 80697000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 80697000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 80697000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 80697000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Interest Income: -17345000.00
EMR.AX cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: -4203000.00
EMR.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -32220000.00
EMR.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -32220000.00
EMR.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -17345000.00
EMR.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -15268000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Net PPE: 431528000.00
EMR.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -5885000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 557968000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Non Current Deferred Assets: 4368000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Assets: 4368000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 463000.00
EMR.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: 176791000.00
EMR.AX income_statement (annual, 2024-06-30) — Normalized Income: 80697000.00
EMR.AX income_statement (annual, 2024-06-30) — Operating Income: 151926000.00
EMR.AX income_statement (annual, 2024-06-30) — Operating Revenue: 366038000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 656112660.00
EMR.AX cash_flow (annual, 2024-06-30) — Other Cash Paymentsfrom Operating Activities: -31459000.00
EMR.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: 10025000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Current Assets: 228000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Current Liabilities: 31520000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 9612000.00
EMR.AX income_statement (annual, 2024-06-30) — Other Gand A: 1782000.00
EMR.AX income_statement (annual, 2024-06-30) — Other Income Expense: -14538000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Inventories: 45961000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Investments: 3321000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 70143000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Non Current Liabilities: 1871000.00
EMR.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: -14538000.00
EMR.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 40993000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Payable: 22209000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Properties: 316561000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 10595000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 502000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Payables: 39824000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 39824000.00
EMR.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -158330000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 1624000.00
EMR.AX income_statement (annual, 2024-06-30) — Pretax Income: 120043000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Properties: 68883000.00
EMR.AX cash_flow (annual, 2024-06-30) — Purchase Of Business: -174000.00
EMR.AX cash_flow (annual, 2024-06-30) — Purchase Of Investment: -4203000.00
EMR.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -5885000.00
EMR.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Customers: 365787000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Receivables: 10646000.00
EMR.AX income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 125630000.00
EMR.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 36964000.00
EMR.AX income_statement (annual, 2024-06-30) — Rent And Landing Fees: 232000.00
EMR.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -32220000.00
EMR.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -272000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: 95141000.00
EMR.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 8511000.00
EMR.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 10525000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Share Issued: 656112660.00
EMR.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 557968000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 557968000.00
EMR.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
EMR.AX income_statement (annual, 2024-06-30) — Tax Provision: 39346000.00
EMR.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.33
EMR.AX cash_flow (annual, 2024-06-30) — Taxes Refund Paid Direct: -34414000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Total Assets: 712422000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 557968000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 557968000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 154454000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 509360000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 34920000.00
EMR.AX income_statement (annual, 2024-06-30) — Total Other Finance Cost: 2596000.00
EMR.AX balance_sheet (annual, 2024-06-30) — Working Capital: 83528000.00
EMR.AX income_statement (annual, 2025-06-30) — +Operating Expense: 82687000.00
EMR.AX income_statement (annual, 2025-06-30) — +Total Revenue: 430414000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Accounts Payable: 14515000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 14515000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -76685000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -76685000.00
EMR.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 656931000.00
EMR.AX income_statement (annual, 2025-06-30) — Basic EPS: 0.13
EMR.AX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 144101000.00
EMR.AX cash_flow (annual, 2025-06-30) — Capital Expenditure: -17714000.00
EMR.AX cash_flow (annual, 2025-06-30) — Capital Expenditure Reported: -1349000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Capital Lease Obligations: 21931000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 21931000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Capital Stock: 452336000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 452336000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 201387000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 201387000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 201387000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 201387000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Cash Equivalents: 110000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 110000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Cash Financial: 201277000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 201277000.00
EMR.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: -77499000.00
EMR.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: -26116000.00
EMR.AX cash_flow (annual, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: 154669000.00
EMR.AX cash_flow (annual, 2025-06-30) — Changes In Cash: 51054000.00
EMR.AX cash_flow (annual, 2025-06-30) — Classesof Cash Payments: -230280000.00
EMR.AX cash_flow (annual, 2025-06-30) — Classesof Cash Receiptsfrom Operating Activities: 435117000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Common Stock: 452336000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 452336000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 655440000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 655440000.00
EMR.AX cash_flow (annual, 2025-06-30) — Common Stock Issuance: 694000.00
EMR.AX cash_flow (annual, 2025-06-30) — Common Stock Payments: -25000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Construction In Progress: 16560000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 16560000.00
EMR.AX income_statement (annual, 2025-06-30) — Cost Of Revenue: 185769000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Current Assets: 246397000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Current Assets: 246397000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Current Capital Lease Obligation: 9650000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 9650000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Current Debt And Capital Lease Obligation: 9650000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 9650000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 25914000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 25914000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Current Deferred Taxes Liabilities: 25914000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Taxes Liabilities: 25914000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Current Liabilities: 68132000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 68132000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Current Provisions: 1969000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Current Provisions: 1969000.00
EMR.AX income_statement (annual, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 530000.00
EMR.AX income_statement (annual, 2025-06-30) — Depreciation And Amortization In Income Statement: 530000.00
EMR.AX income_statement (annual, 2025-06-30) — Depreciation Income Statement: 530000.00
EMR.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 663202120.00
EMR.AX income_statement (annual, 2025-06-30) — Diluted EPS: 0.13
EMR.AX income_statement (annual, 2025-06-30) — EBIT: 164390000.00
EMR.AX income_statement (annual, 2025-06-30) — EBITDA: 164920000.00
EMR.AX cash_flow (annual, 2025-06-30) — Effect Of Exchange Rate Changes: 6232000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Employee Benefits: 720000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 720000.00
EMR.AX cash_flow (annual, 2025-06-30) — End Cash Position: 201387000.00
EMR.AX cash_flow (annual, 2025-06-30) — Financing Cash Flow: -77499000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Foreign Currency Translation Adjustments: 5134000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 5134000.00
EMR.AX cash_flow (annual, 2025-06-30) — Free Cash Flow: 136955000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 20354000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 20354000.00
EMR.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 15478000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Gross PPE: 491307000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 491307000.00
EMR.AX income_statement (annual, 2025-06-30) — Gross Profit: 244645000.00
EMR.AX cash_flow (annual, 2025-06-30) — Income Tax Paid Supplemental Data: 57636000.00
EMR.AX income_statement (annual, 2025-06-30) — Interest Expense: 13113000.00
EMR.AX income_statement (annual, 2025-06-30) — Interest Expense Non Operating: 13113000.00
EMR.AX income_statement (annual, 2025-06-30) — Interest Income: 7377000.00
EMR.AX income_statement (annual, 2025-06-30) — Interest Income Non Operating: 7377000.00
EMR.AX cash_flow (annual, 2025-06-30) — Interest Paid Cff: -31547000.00
EMR.AX cash_flow (annual, 2025-06-30) — Interest Received Direct: 7468000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Inventory: 35987000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Inventory: 35987000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Invested Capital: 655440000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 655440000.00
EMR.AX cash_flow (annual, 2025-06-30) — Investing Cash Flow: -26116000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Investments And Advances: 11919000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 11919000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Investmentsin Associatesat Cost: 7254000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 7254000.00
EMR.AX cash_flow (annual, 2025-06-30) — Issuance Of Capital Stock: 694000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Land And Improvements: 29092000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 29092000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Leases: 546000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Leases: 546000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Long Term Capital Lease Obligation: 12281000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 12281000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 12281000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 12281000.00
EMR.AX cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -30042000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Long Term Equity Investment: 7254000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 7254000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Long Term Provisions: 17024000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 17024000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 76833000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 76833000.00
EMR.AX cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: 669000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Income: 87609000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: 87609000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: 87609000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 87609000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 87609000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: 87609000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Interest Income: -8030000.00
EMR.AX cash_flow (annual, 2025-06-30) — Net Investment Purchase And Sale: -8402000.00
EMR.AX cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -30042000.00
EMR.AX cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -30042000.00
EMR.AX income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: -8030000.00
EMR.AX cash_flow (annual, 2025-06-30) — Net Other Financing Charges: -16579000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Net PPE: 414622000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Net PPE: 414622000.00
EMR.AX cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -16365000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 655440000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 655440000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Non Current Accounts Receivable: 2000000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 2000000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Non Current Deferred Assets: 2047000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2047000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Non Current Deferred Taxes Assets: 2047000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2047000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 720000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 720000.00
EMR.AX income_statement (annual, 2025-06-30) — Normalized EBITDA: 164920000.00
EMR.AX income_statement (annual, 2025-06-30) — Normalized Income: 87609000.00
EMR.AX income_statement (annual, 2025-06-30) — Operating Income: 161958000.00
EMR.AX income_statement (annual, 2025-06-30) — Operating Revenue: 430414000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 657590123.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 657590123.00
EMR.AX cash_flow (annual, 2025-06-30) — Other Cash Paymentsfrom Operating Activities: -57782000.00
EMR.AX cash_flow (annual, 2025-06-30) — Other Cash Receiptsfrom Operating Activities: 4702000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: 15220000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 15220000.00
EMR.AX income_statement (annual, 2025-06-30) — Other Gand A: 2383000.00
EMR.AX income_statement (annual, 2025-06-30) — Other Income Expense: -2651000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Inventories: 35987000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Inventories: 35987000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Investments: 4665000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Investments: 4665000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Non Current Assets: 79133000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 79133000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Non Current Liabilities: 2521000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 2521000.00
EMR.AX income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: -2651000.00
EMR.AX income_statement (annual, 2025-06-30) — Other Operating Expenses: 66679000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Payable: 16078000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 16078000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Properties: 304074000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Properties: 304074000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Other Receivables: 7741000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 7741000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Payables: 30593000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Payables: 30593000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 30593000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 30593000.00
EMR.AX cash_flow (annual, 2025-06-30) — Paymentsto Suppliersfor Goodsand Services: -172498000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 6000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Prepaid Assets: 1282000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1282000.00
EMR.AX income_statement (annual, 2025-06-30) — Pretax Income: 151277000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Properties: 64202000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Properties: 64202000.00
EMR.AX cash_flow (annual, 2025-06-30) — Purchase Of Investment: -8402000.00
EMR.AX cash_flow (annual, 2025-06-30) — Purchase Of PPE: -16365000.00
EMR.AX cash_flow (annual, 2025-06-30) — Receiptsfrom Customers: 430415000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Receivables: 7741000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 7741000.00
EMR.AX income_statement (annual, 2025-06-30) — Reconciled Cost Of Revenue: 185769000.00
EMR.AX income_statement (annual, 2025-06-30) — Reconciled Depreciation: 530000.00
EMR.AX income_statement (annual, 2025-06-30) — Rent And Landing Fees: 234000.00
EMR.AX cash_flow (annual, 2025-06-30) — Repayment Of Debt: -30042000.00
EMR.AX cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: -25000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: 182750000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 182750000.00
EMR.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 12861000.00
EMR.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 15478000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Share Issued: 657590123.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 657590123.00
EMR.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 655440000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 655440000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: 655440000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 655440000.00
EMR.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
EMR.AX income_statement (annual, 2025-06-30) — Tax Provision: 63668000.00
EMR.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.30
EMR.AX cash_flow (annual, 2025-06-30) — Taxes Refund Paid Direct: -57636000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Total Assets: 756118000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 756118000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 655440000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 655440000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Total Debt: 21931000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Total Debt: 21931000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 655440000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 655440000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 100678000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 100678000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 509721000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 509721000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 32546000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 32546000.00
EMR.AX income_statement (annual, 2025-06-30) — Total Other Finance Cost: 2294000.00
EMR.AX balance_sheet (annual, 2025-06-30) — Working Capital: 178265000.00
EMR.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: 178265000.00
EMR.DE balance_sheet (annual, 2021-09-30) — Commercial Paper: 334000000.00
EMR.DE cash_flow (annual, 2021-09-30) — Gain Loss On Sale Of Business: 0.00
EMR.DE balance_sheet (annual, 2021-09-30) — Long Term Provisions: 256000000.00
EMR.DE cash_flow (annual, 2021-09-30) — Net Investment Purchase And Sale: 0.00
EMR.DE cash_flow (annual, 2021-09-30) — Sale Of Investment: 0.00
EMR.DE income_statement (annual, 2022-09-30) — +Operating Expense: 3950000000.00
EMR.DE income_statement (annual, 2022-09-30) — +Total Revenue: 13804000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Accounts Payable: 1276000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Accounts Receivable: 2261000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -3151000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 57000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Allowance For Doubtful Accounts Receivable: -100000000.00
EMR.DE income_statement (annual, 2022-09-30) — Amortization: 336000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Amortization Cash Flow: 530000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Amortization Of Intangibles: 530000000.00
EMR.DE income_statement (annual, 2022-09-30) — Amortization Of Intangibles Income Statement: 336000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Asset Impairment Charge: 0.00
EMR.DE balance_sheet (annual, 2022-09-30) — Assets Held For Sale Current: 1398000000.00
EMR.DE income_statement (annual, 2022-09-30) — Basic Average Shares: 591400000.00
EMR.DE income_statement (annual, 2022-09-30) — Basic EPS: 5.46
EMR.DE cash_flow (annual, 2022-09-30) — Beginning Cash Position: 2354000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 1500000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Capital Expenditure: -299000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Capital Expenditure Reported: -299000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Capital Lease Obligations: 312000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Capital Stock: 477000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 1804000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 1804000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Cash Dividends Paid: -1223000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: 2048000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -5684000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: 2048000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Cash From Discontinued Investing Activities: 350000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Cash From Discontinued Operating Activities: 874000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Account Payable: 147000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Accrued Expense: 74000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Inventory: -334000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Other Current Assets: -56000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Payable: 147000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: 221000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Receivables: -143000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Change In Working Capital: -312000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Changes In Cash: -364000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Commercial Paper: 1599000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Common Stock: 477000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Common Stock Dividend Paid: -1223000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Common Stock Equity: 10364000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Common Stock Payments: -500000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Construction In Progress: 390000000.00
EMR.DE income_statement (annual, 2022-09-30) — Cost Of Revenue: 7498000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Current Accrued Expenses: 3038000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Current Assets: 8506000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Current Debt: 2115000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 2115000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Current Liabilities: 7777000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Depreciation: 312000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 842000000.00
EMR.DE income_statement (annual, 2022-09-30) — Depreciation Amortization Depletion Income Statement: 336000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 842000000.00
EMR.DE income_statement (annual, 2022-09-30) — Depreciation And Amortization In Income Statement: 336000000.00
EMR.DE income_statement (annual, 2022-09-30) — Diluted Average Shares: 596300000.00
EMR.DE income_statement (annual, 2022-09-30) — Diluted EPS: 5.41
EMR.DE income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: 3231000000.00
EMR.DE income_statement (annual, 2022-09-30) — EBIT: 2660000000.00
EMR.DE income_statement (annual, 2022-09-30) — EBITDA: 3502000000.00
EMR.DE income_statement (annual, 2022-09-30) — Earnings From Equity Interest: 453000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: -186000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Employee Benefits: 427000000.00
EMR.DE cash_flow (annual, 2022-09-30) — End Cash Position: 1804000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Financing Cash Flow: 2048000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Finished Goods: 417000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Free Cash Flow: 2623000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Gain Loss On Investment Securities: -453000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of Business: -939000000.00
EMR.DE income_statement (annual, 2022-09-30) — Gain On Sale Of Business: -135000000.00
EMR.DE income_statement (annual, 2022-09-30) — Gain On Sale Of Security: 18000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: -1485000000.00
EMR.DE income_statement (annual, 2022-09-30) — General And Administrative Expense: 3614000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Goodwill: 13946000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 20518000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Gross Accounts Receivable: 2361000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Gross PPE: 5390000000.00
EMR.DE income_statement (annual, 2022-09-30) — Gross Profit: 6306000000.00
EMR.DE income_statement (annual, 2022-09-30) — Interest Expense: 228000000.00
EMR.DE income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 228000000.00
EMR.DE income_statement (annual, 2022-09-30) — Interest Income: 34000000.00
EMR.DE income_statement (annual, 2022-09-30) — Interest Income Non Operating: 34000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Inventory: 1742000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Invested Capital: 20738000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Investing Cash Flow: -5334000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Investments And Advances: 0.00
EMR.DE cash_flow (annual, 2022-09-30) — Issuance Of Debt: 5378000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Land And Improvements: 200000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Liabilities Heldfor Sale Non Current: 167000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 312000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Long Term Debt: 8259000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 8571000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 2975000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -522000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Long Term Equity Investment: 0.00
EMR.DE balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 3300000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Minority Interest: 5952000000.00
EMR.DE income_statement (annual, 2022-09-30) — Minority Interests: 1000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Business Purchase And Sale: -5685000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: -500000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Net Debt: 8570000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Income: 3231000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Income Common Stockholders: 3231000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Income Continuous Operations: 1883000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Income Discontinuous Operations: 1347000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: 3231000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: 1884000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: 1883000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: 3230000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Interest Income: -194000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: 438000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: 3691000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: 2453000000.00
EMR.DE income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: -194000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Other Financing Charges: 80000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Other Investing Changes: -138000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Net PPE: 2239000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Net Short Term Debt Issuance: 1238000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Net Tangible Assets: -10154000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Non Current Deferred Liabilities: 1714000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Liabilities: 1714000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Non Current Note Receivables: 0.00
EMR.DE balance_sheet (annual, 2022-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 427000000.00
EMR.DE income_statement (annual, 2022-09-30) — Normalized EBITDA: 3785000000.00
EMR.DE income_statement (annual, 2022-09-30) — Normalized Income: 2103042000.00
EMR.DE cash_flow (annual, 2022-09-30) — Operating Cash Flow: 2922000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Operating Gains Losses: -494000000.00
EMR.DE income_statement (annual, 2022-09-30) — Operating Income: 2356000000.00
EMR.DE income_statement (annual, 2022-09-30) — Operating Revenue: 13804000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 591400000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Other Current Assets: 1301000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Other Current Borrowings: 516000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Other Current Liabilities: 1348000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Other Equity Adjustments: -1485000000.00
EMR.DE income_statement (annual, 2022-09-30) — Other Gand A: 3614000000.00
EMR.DE income_statement (annual, 2022-09-30) — Other Income Expense: 270000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 6572000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Other Non Cash Items: 4000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Other Non Current Assets: 4409000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Other Non Current Liabilities: 700000000.00
EMR.DE income_statement (annual, 2022-09-30) — Other Non Operating Income Expenses: 100000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Payables: 1276000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 4314000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Pension And Employee Benefit Expense: -41000000.00
EMR.DE income_statement (annual, 2022-09-30) — Pretax Income: 2432000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Properties: 0.00
EMR.DE cash_flow (annual, 2022-09-30) — Purchase Of Business: -5702000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Raw Materials: 1325000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Receivables: 2261000000.00
EMR.DE income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 6992000000.00
EMR.DE income_statement (annual, 2022-09-30) — Reconciled Depreciation: 842000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Repayment Of Debt: -1687000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Repurchase Of Capital Stock: -500000000.00
EMR.DE income_statement (annual, 2022-09-30) — Restructuring And Mergern Acquisition: 166000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Retained Earnings: 28053000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Sale Of Business: 17000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Sale Of Investment: 438000000.00
EMR.DE income_statement (annual, 2022-09-30) — Selling General And Administration: 3614000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Share Issued: 953400000.00
EMR.DE cash_flow (annual, 2022-09-30) — Short Term Debt Issuance: 2403000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Short Term Debt Payments: -1165000000.00
EMR.DE income_statement (annual, 2022-09-30) — Special Income Charges: -301000000.00
EMR.DE cash_flow (annual, 2022-09-30) — Stock Based Compensation: 125000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Stockholders Equity: 10364000000.00
EMR.DE balance_sheet (annual, 2022-09-30) — Tangible Book Value: -10154000000.00